TCMD vs MMSI

For growth investors, Tactile Systems Technology, Inc.

(TCMD) is the stronger pick with 12. 5% revenue growth year-over-year, versus 11. 7% for Merit Medical Systems, Inc. (MMSI). Merit Medical Systems, Inc. (MMSI) offers the better valuation at 28. 9x trailing P/E (15. 3x forward), making it the more compelling value choice. Analysts rate Tactile Systems Technology, Inc. (TCMD) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Merit Medical Systems, Inc.

(MMSI) is the cheapest at 28. 9x versus Tactile Systems Technology, Inc. at 30. 9x. On forward P/E, Merit Medical Systems, Inc. is actually cheaper at 15. 3x.

Over the past 5 years, Merit Medical Systems, Inc.

(MMSI) delivered a total return of -5. 0%, compared to -55. 6% for Tactile Systems Technology, Inc. (TCMD). Over 10 years, the gap is even starker: MMSI returned +215. 9% versus TCMD's +128. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Merit Medical Systems, Inc.

(MMSI) is the lower-risk stock at 0. 71β versus Tactile Systems Technology, Inc. 's 0. 99β — meaning TCMD is approximately 40% more volatile than MMSI relative to the S&P 500. On balance sheet safety, Tactile Systems Technology, Inc. (TCMD) carries a lower debt/equity ratio of 7% versus 57% for Merit Medical Systems, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Tactile Systems Technology, Inc.

(TCMD) is pulling ahead at 12. 5% versus 11. 7% for Merit Medical Systems, Inc. (MMSI). On earnings-per-share growth, the picture is similar: Tactile Systems Technology, Inc. grew EPS 17. 1% year-over-year, compared to 4. 9% for Merit Medical Systems, Inc.. Over a 3-year CAGR, TCMD leads at 10. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Merit Medical Systems, Inc.

(MMSI) is the more profitable company, earning 8. 5% net margin versus 5. 8% for Tactile Systems Technology, Inc. — meaning it keeps 8. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MMSI leads at 12. 2% versus 8. 9% for TCMD. At the gross margin level — before operating expenses — TCMD leads at 75. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Merit Medical Systems, Inc.

(MMSI) trades at 15. 3x forward P/E versus 22. 2x for Tactile Systems Technology, Inc. — 6. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MMSI: 54. 1% to $95. 00.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Merit Medical Systems, Inc.

(MMSI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 71), +215. 9% 10Y return). Both have compounded well over 10 years (MMSI: +215. 9%, TCMD: +128. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.